Sun BioPharma Files Form 10-Q for Third Quarter 2015 and Provides Business Update
Presentations to Focus on Pre-Clinical Data for Company’s Lead Development Candidate, SBP-101, for the Treatment of Pancreatic Diseases
Healthcare Executive Brings Extensive Public Company Financial Experience to Leadership Team
Two Experienced Healthcare Executives Join Board as Company Prepares to Enroll First Patient in Phase 1 Clinical Trial
Healthcare Executive Brings Extensive Clinical & Public Markets Experience to Sun’s Management Team
Company’s clinical development program focuses on novel approach to treatment of pancreatic cancer
Phase 1 Clinical Study Expected to Begin By End of Year
Events & Presentations